Because of these effects, semaglutide has gained attention not only for blood sugar control in diabetes but also for weight loss
Most high-quality research shows clear differences in average weight loss: Tirzepatide (Zepbound) In large clinical trials (SURMOUNT-1), tirzepatide produced 15% to 22.5% total body weight loss , depending on the dose4
For the first time, someone actually listened to me during my visit without typing or multitasking
Current NHS eligibility criteria for semaglutide 2.4 mg (Wegovy) for weight management, according to NICE TA875, include: Body Mass Index (BMI) 35 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea) For people from certain high-risk ethnic groups (such as South Asian, Chinese, Black African, or African-Caribbean), lower BMI thresholds apply (typically reduced by 2.5 kg/m) Treatment must be prescribed within specialist weight management services only Treatment is limited to a maximum duration of 2 years Must be used as an adjunct to a reduced-calorie diet and increased physical activity Liraglutide 3 mg (Saxenda) availability varies significantly across NHS regions and is not routinely commissioned in many areas
Low levels of glutathione send messages to trigger apoptosis or cell death